$VAPR E-Cite Motors Interview With COO Gene Langmesser

New Post Public Reply Private Reply Replies (0) Message Board
louied91
379
$VAPR E-Cite Motors Interview With COO Gene Langmesser Answering Shareholders Questions Available Now on Company’s Website


https://www.digitaljournal.com/pr/vapr-e-cite...ys-website

BOTHELL, WA / ACCESSWIRE / April 11, 2022 / VaporBrands International, Inc. (OTC PINK:VAPR) dba E-Cite Motors Group an innovative Electric Vehicle manufacturer announced that the video interview with its COO legendary designer Gene Langmesser addressing questions submitted by shareholders is now available at www.ecitemotors.com. The interview was conducted by investor/ analyst Mark Schaftlein on March 6, 2022.

Subjects discussed included the Company’s competitive advantage over other EV auto manufacturers, the types of vehicles that will be available first to customers, plans to change the name and symbol of the Company, Gene’s background, and his favorite past projects.

Questions submitted specifically by shareholders such as how E-Cite will address safety concerns given it is not subject to current safety certifications, general design of the vehicle, and the fact that the vehicles are fully engineered state of the art new vehicles that have VIN Numbers for road use and are sold as complete vehicles. Also discussed is why the vehicles will resemble iconic cars from more than 25 years ago.

Note* E-Cites vehicles are in no way categorized as “Kit Cars” as they are manufactured new vehicles.

COO Gene Langmesser commented: “I want to thank all the shareholders and interested parties that took their time to ask very inquisitive questions. I am looking forward to being able to share more updates as we move forward and encourage anyone to ask questions as details are released. I also want to express my gratitude for Mark Schaftlein for having me in this interview. He is truly as genuine as his reputation and I welcome the opportunity to return in the future.”

Gene Langmesser has extensive years of domestic and international professional experience in the Sales, Business Development, Executive Business Operations, and the Product Design Engineering industry. He is an executive and has held these positions in both aerospace and automotive sectors of the world. Gene formed many teams over his career and has executed programs for both domestic and international Markets. He worked his way up through all the key job classifications and has performed these tasks from “art to part” interfacing with the entire executive team, sales and technical. In his career Gene set-up offices, design, engineering, rapid prototyping, mock-up, and fabrication facilities. He has conducted international business in Germany, Italy, England, France, Poland, and Mexico.

In 2016 Gene and N2A were task to design and build the first ever Hydrogen Hybrid Semi-Truck, by Nikola Motors. They delivered the entire carbon fiber body, all lighting, glass, mirrors, grills, emblems, full interior, dash, gauges, beds, seats, and many other aspects. N2A was also contracted by Nikola to build much of the first ever all-electric UTV 72 kWh EV buggy project that can hit zero to 60 in about 3 seconds.

In addition to leading design and product development teams and prototyping for automobile manufacturers such as Porsche, Mercedes, Lexus, Ford, Hyundai, and others, he has also created or built many movie cars or props. Most notably the futuristic Lexus 2054 driven in “Minority Report”, the taxis in “Taxi”, Fighter ships in “Battlestar Galactica” the Batmobile in “Batman and Robin”, and the Terminators bodies in Terminator 3.

Unlike competitors Tesla, Nikola, Polestar, Lucid, VW, Ford, Jaguar, and others, E-cite is not required to meet any of the safety or other costly certifications of a traditional auto manufacturer making the ease and timeline of offering new vehicles to market significantly more favorable. Whereas the initial timeline to be able to deliver a production vehicle to market generally exceeds 3 years and often longer at a very high cost, E-Cite expects to be delivering its first production vehicles for the 2023 model year. That is less than 12 months from inception to the showroom.

This is possible because E-Cites vehicles qualify under the “Low Volume Vehicle Manufacturers Act of 2015” In 2015 Congress enacted a bill into law directing the NHSTA to establish a program allowing low volume motor vehicle manufacturers to produce a limited number of vehicles annually within a regulatory system that addresses the unique safety and financial issues associated with limited production, and to direct the EPA to allow low volume motor vehicle manufacturers to install engines from vehicles that have been issued certificates of conformity. Although they were given one year to establish this new program it took until January 2021 until the NHSTA issued a final ruling to allow low volume vehicle manufacturing. Under the act car manufacturers are exempt from all the safety standards but they must meet current emissions standards. There are no emissions standards for EV vehicles.

E-Cite Motors has developed a modular design that will be engineered to allow the production of vehicles utilizing a skateboard style chassis that uses hub electric motors. As the system is fully modular this allows for configurations ranging from low powered batteries and only a single 100hp motor on up to a high powered 1000hp performance vehicle utilizing AWD and 4 250hp motors.

VaporBrands International Inc. (VAPR) Stock Research Links

VAPR Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 184

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 199

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 136

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 184

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 299

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 295

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 249

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 153

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Fluence Energy Hits Legal Snag: Investors Called to Act

Updated Category News Views 168

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 132

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading

Top 5 Most Recently Viewed Articles

Telenor Group's Q3 2024 Results: Join Us for Insights

Updated Category News Views 304

Join Telenor Group for a Detailed Overview of Q3 2024 Results Telenor Group invites you to participate in the forthcoming results announcement for the third quarter of 2024. This event is an exciting opportunity to gain crucial insights into the company's performance and strategic direction. Details of the Presentation The presentation is scheduled for a morning session,...

Continue Reading
Azafaros Secures Key Approvals for Phase 3 Trials of Nizubaglustat

Updated Category News Views 322

Azafaros Achieves Critical Milestones in Regulatory Approvals Azafaros B.V. has recently announced significant advancements regarding its lead asset, nizubaglustat, which has garnered orphan drug designation from both United States and European regulatory authorities. This designation is specifically for the treatment of GM1 gangliosidosis, a rare lysosomal storage...

Continue Reading
Refresco's Leadership Changes Set the Stage for Future Growth

Updated Category News Views 373

Refresco's Leadership Changes Set the Stage for Future Growth Refresco, a prominent independent beverage solutions provider, recently announced that its Chief Executive Officer, Hans Roelofs, will be retiring. This transition marks a significant moment not only for Hans but also for the company, which has been under his stewardship for nearly two decades. Hans Roelofs: A...

Continue Reading
How a $1000 Investment in Home Depot Would Have Grown

Updated Category News Views 148

Home Depot: A Strong Investment Choice Home Depot has proven itself as a robust performer in the stock market over the years. With an impressive market capitalization of $379.06 billion, it has outshone the market by approximately 6.8% annually. The average annual return of 19.17% that the company has generated is nothing short of remarkable. This growth exemplifies the...

Continue Reading
AI Stocks Face Market Correction Amid Recovery Clouds

Updated Category News Views 207

The Shift in AI Stock Momentum The exhilarating rally that captivated investors in the spring is now showing signs of fatigue. What we're witnessing is not merely a dip, but a significant reality check across global markets. Japanese indices experienced dramatic declines, with the Nikkei plummeting over 4%—its steepest single-day drop in recent memory. Traders are...

Continue Reading